Response to "Epidemiology of neuromyelitis optica spectrum disorder''

G H Dale^{1

2}, K Bacher Svendsen¹, M C Gjelstrup², T Christensen², G Houen³, E Nielsen⁴, T Bek⁵, T Petersen¹

Affiliations

¹ Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.
² Department of Biomedicine, Aarhus University, Aarhus, Denmark.
³ Department of Autoimmunology and Biomarkers, Statens Serum Institut, Copenhagen, Denmark.
⁴ Department of Neuroradiology, Aarhus University Hospital, Aarhus, Denmark.
⁵ Department of Ophthalmology, Aarhus University Hospital, Aarhus, Denmark.

Comment

G H Dale et al. Acta Neurol Scand. 2018 Jun.

. 2018 Jun;137(6):628-629.

doi: 10.1111/ane.12937.

G H Dale^{1

2}, K Bacher Svendsen¹, M C Gjelstrup², T Christensen², G Houen³, E Nielsen⁴, T Bek⁵, T Petersen¹

¹ Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.
² Department of Biomedicine, Aarhus University, Aarhus, Denmark.
³ Department of Autoimmunology and Biomarkers, Statens Serum Institut, Copenhagen, Denmark.
⁴ Department of Neuroradiology, Aarhus University Hospital, Aarhus, Denmark.
⁵ Department of Ophthalmology, Aarhus University Hospital, Aarhus, Denmark.

No abstract available

Keywords: demyelinating diseases; immunology; neuroepidemiology; neuroimaging.

Comment on

Incidence of neuromyelitis optica spectrum disorder in the Central Denmark Region.
Dale GH, Svendsen KB, Gjelstrup MC, Christensen T, Houen G, Nielsen E, Bek T, Petersen T. Dale GH, et al. Acta Neurol Scand. 2018 Jun;137(6):582-588. doi: 10.1111/ane.12903. Epub 2018 Jan 22. Acta Neurol Scand. 2018. PMID: 29359475
Epidemiology of neuromyelitis optica spectrum disorder.
Asgari N, Lillevang ST, Skejoe HPB, Falah M, Stenager E, Kyvik KO. Asgari N, et al. Acta Neurol Scand. 2018 Jun;137(6):626-627. doi: 10.1111/ane.12936. Acta Neurol Scand. 2018. PMID: 29732539 No abstract available.